NaranjoCABustoUSellersEM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245. doi:10.1038/clpt.1981.154.
2.
BardaNDaganNBen-ShlomoB, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385:1078-1090. doi:10.1056/NEJMoa2110475.
3.
CaiCPengYShenE, et al. A comprehensive analysis of the efficacy and safety of COVID-19 vaccines. Mol Ther. 2021;29:2794-2805. doi:10.1016/j.ymthe.2021.08.001.
4.
DiazGAParsonsGTGeringSK, et al. Myocarditis and pericarditis after vaccination for COVID-19. JAMA. 2021;326:1210-1212. doi:10.1001/jama.2021.13443.
5.
LazarosGAnastassopoulouCHatziantoniouS, et al. A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States. Vaccine. 2021;39:6585-6590. doi:10.1016/j.vaccine.2021.09.078.
